Location of Repository

A tetravalent dengue nanoparticle stimulates antibody production in mice. Journal of Nanobiotechnology

By Elisângela Fátima Silva, Mariana Orsi, Angela Leao Andrade, Rosana Zacarias Domingues, Breno de Mello Silva, Helena Rocha Corrêa de Araújo, Paulo Filemon Paolucci Pimenta, Michael S Diamond, Eliseu Soares de Oliveira Rocha, Erna Geessien Kroon, Luiz Cosme Cotta Malaquias and Luiz Felipe Leomil Coelho


Background: Dengue is a major public health problem worldwide, especially in the tropical and subtropical regions of the world. Infection with a single Dengue virus (DENV) serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients experiencing secondary infection with a different serotype progresses to the severe form of the disease, dengue hemorrhagic fever/dengue shock syndrome. Currently, there are no licensed vaccines or antiviral drugs to prevent or treat dengue infections. Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines. Findings: Here, we used a murine model to evaluate the IgG production after administration of inactivated DENV corresponding to all four serotypes adsorbed to bovine serum albumin nanoparticles. This formulation induced a production of anti-DENV IgG antibodies (p < 0.001). However, plaque reduction neutralization assays with the four DENV serotypes revealed that these antibodies have no neutralizing activity in the dilutions tested. Conclusions: Our results show that while the nanoparticle system induces humoral responses against DENV, further investigation with different DENV antigens will be required to improve immunogenicity, epitope specicity, and functional activity to make this platform a viable option for DENV vaccines

Topics: inactivated Dengue vírus, Nanoparticles, humoral response
Publisher: BioMed Central
Year: 2012
OAI identifier: oai:agregador.ibict.br.RI_FIOCRUZ:oai:localhost:icict/7945
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.rcaap.pt/detail.jsp... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.